Bioxiness Pharmaceuticals

About:

Bioxiness Pharmaceuticals develops novel antimicrobial compounds for the treatment of severe bacterial infections.

Top Investors: LaunchCapital

Description:

Bioxiness Pharmaceuticals is a California-based pre-clinical stage company, developing a novel class of antimicrobial compounds for the treatment of severe bacterial infections. Bioxiness compounds are new chemical class (NCC) developed towards critical target-enzymes within the pathogenic bacterial cells. These molecules employ unique mode of antimicrobial actions.

Total Funding Amount:

$805000

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Hercules, California, United States

Founded Date:

2007-01-01

Contact Email:

info(AT)bioxiness.com

Founders:

Mansour Bassiri

Number of Employees:

1-10

Last Funding Date:

2016-09-21

IPO Status:

Private

Industries: